Elizabeth Warren and the Death of Genetic Privacy
By Noah Feldman,
Bloomberg
| 10. 15. 2018
In theory, taking a DNA test to reveal your ancestry is optional. But it’s on its way to becoming obligatory. Massachusetts Senator Elizabeth Warren announced Monday that she had submitted her DNA to ascertain that she does in fact have Native American ancestry — after President Donald Trump had taunted her by saying he would throw a testing kit at her. For those of us not in national politics, a study in the journal Science last week claimed that within a few years, it will be possible to identify some 90 percent of white Americans by using genetic databases that include their cousins. Even if you don’t take the test yourself, someone has taken it for you.
The takeaway from these developments is simple: Genetic privacy is well on its way to becoming obsolete, thanks to the voluntary use of cheap DNA testing technology and the astonishing power of statistics. These factors are changing our social norms and expectations. The only thing that could potentially preserve genetic privacy now would be strict government regulation. That’s pretty unlikely, and even if...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...